✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Zim Laboratories Ltd.

ZIMLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹367 Cr.
P/E
55.72

Zim Laboratories Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
367 Cr
PE
PE
55.72
Prom Holding
Prom Holding
33.26 %
ROE (%)
ROE (%)
4.82
ROCE (%)
ROCE (%)
9.62
Div Yield (%)
Div Yield (%)
-
Sales
Sales
365 Cr
OPM (%)
OPM (%)
9.90 %
Debt to Equity
Debt to Equity
0.45
View more
Edit Ratio's

About

Zim Laboratories Ltd has established itself as one of the preferred healthcare solution provi… Read more
Low
64
52W Range
High
127
  • Zim Laboratories
  • Trident Lifeline
  • Albert David
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Capex

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Customers

    • Gufic Biosciences Ltd.
    • RPG Life Sciences Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Alkem Laboratories Ltd.
    • Mankind Pharma

    FAQs on Zim Laboratories Ltd. Business

    Zim Laboratories Ltd is a leading healthcare solution provider specializing in New Drug Delivery Systems. They have developed innovative technologies and products in areas such as Pellets, Multiplets, Resinates, Herbals, and Diagnostics.

    Zim Laboratories major competitors are Trident Lifeline, Albert David, Medico Remedies, Gennex Lab, Jenburkt Pharma, Lyka Labs, Shivalik Rasayan.
    Market Cap of Zim Laboratories is ₹367 Crs.
    While the median market cap of its peers are ₹392 Crs.

    Zim Laboratories seems to be less financially stable compared to its competitors.
    Altman Z score of Zim Laboratories is 2.69 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Dec Mar Jun Sep Dec Jun Sep Dec
    Investor Presentation May Aug Nov Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Dec Dec Feb Jun Sep Dec
    Conference Call May Jun Nov Mar Sep Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Zim Laboratories Ltd.
    Zim Laboratories - A very under-researched but very impressive Small Cap Pharma Company - Mohit Jangir
    Pharmaceuticals
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material